These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26276744)

  • 21. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.
    Backes J; Anzalone D; Hilleman D; Catini J
    Lipids Health Dis; 2016 Jul; 15(1):118. PubMed ID: 27444154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation.
    Schuchardt JP; Neubronner J; Block RC; von Schacky C; Hahn A
    Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):129-34. PubMed ID: 25108576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.
    Fabian CJ; Kimler BF; Zalles CM; Phillips TA; Metheny T; Petroff BK; Havighurst TC; Kim K; Bailey HH; Heckman-Stoddard BM
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1146-55. PubMed ID: 26391916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
    Fabian CJ; Kimler BF; Donnelly JE; Sullivan DK; Klemp JR; Petroff BK; Phillips TA; Metheny T; Aversman S; Yeh HW; Zalles CM; Mills GB; Hursting SD
    Breast Cancer Res Treat; 2013 Nov; 142(1):119-32. PubMed ID: 24141897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density.
    Hudson AG; Reeves KW; Modugno F; Wilson JW; Evans RW; Vogel VG; Gierach GL; Simpson J; Weissfeld JL
    Nutr Cancer; 2013; 65(3):410-6. PubMed ID: 23530640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.
    Donadio JV; Larson TS; Bergstralh EJ; Grande JP
    J Am Soc Nephrol; 2001 Apr; 12(4):791-799. PubMed ID: 11274240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.
    Ford NA; Rossi EL; Barnett K; Yang P; Bowers LW; Hidaka BH; Kimler BF; Carlson SE; Shureiqi I; deGraffenried LA; Fabian CJ; Hursting SD
    Cancer Prev Res (Phila); 2015 Sep; 8(9):796-806. PubMed ID: 26100521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid compositions of serum phospholipids of postmenopausal women: a comparison between Greenland Inuit and Canadians before and after supplementation with fish oil.
    Stark KD; Mulvad G; Pedersen HS; Park EJ; Dewailly E; Holub BJ
    Nutrition; 2002; 18(7-8):627-30. PubMed ID: 12093443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 Fatty Acids Responsive Proteins and Reduction in Breast Density in Obese Postmenopausal Women.
    Sun YW; Xu H; Benitez G; Chen KM; Stanley A; Stanley B; Zhu J; Thompson H; Manni A; El-Bayoumy K
    J Proteome Res; 2019 Sep; 18(9):3461-3469. PubMed ID: 31369706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients.
    Crandell JR; Tartaglia C; Tartaglia J
    Postgrad Med; 2016 Nov; 128(8):859-864. PubMed ID: 27684412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.
    Fabian CJ; Kimler BF; Zalles CM; Klemp JR; Petroff BK; Khan QJ; Sharma P; Setchell KD; Zhao X; Phillips TA; Metheny T; Hughes JR; Yeh HW; Johnson KA
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1342-50. PubMed ID: 20724470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prenatal EPA and DHA on maternal and cord blood insulin sensitivity: a secondary analysis of the mothers, omega 3, and mental health study.
    England JA; Jain J; Holbrook BD; Schrader R; Qualls C; Mozurkewich E
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):452. PubMed ID: 31783739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
    Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study.
    Bayraktar S; Baghaki S; Wu J; Liu DD; Gutierrez-Barrera AM; Bevers TB; Valero V; Sneige N; Arun BK
    Cancer Prev Res (Phila); 2020 Sep; 13(9):795-802. PubMed ID: 32513785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
    Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Calder PC; Byrne CD;
    Contemp Clin Trials; 2014 Mar; 37(2):301-11. PubMed ID: 24556343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary omega-3 fatty acids for women.
    Bourre JM
    Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.